Products

Pasteuria Bioscience, Inc. is commercializing a revolutionary new technology that allows the rapid and cost-effective growth of multiple strains of Pasteuria spp. in traditional commercial fermentation tanks using easily available growth media. This in vitro production process will enable the launch of a less expensive and more effective nematicides, which will not only replace several chemicals with significant safety and effectiveness problems, but will also enable control of nematode damage for which there currently are no safe or cost-effective treatment options.

There are patent applications pending on this technology and Pasteuria Bioscience, Inc. has exclusive worldwide rights to commercialize it.

Scientists first realized that Pasteuria could provide effective nematode control over 50 years ago, and academic and USDA researchers have long considered Pasteuria to be the most promising biological agent for control of plant-parasitic nematodes. But until recently, no one was able to grow these bacteria outside of the body of a nematode. Pasteuria has been produced in-vivo (on living hosts) and used on a very limited basis for nematode control, but the high cost of this production method has prevented its widespread application.

Pasteuria Bioscience currently has multiple strains of Pasteuria spp. in cultivation for control of a variety of nematode pests and an ongoing program of research and development of new strains.  Fermentation scale-up to the pilot scale is underway and the company is in active discussions with several potential commercial-scale fermentation partners. Initial product launch is anticipated for 2009, pending EPA registration and labeling.